BiomX Inc. — Director's Dealing 2022

Aug 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2022-08-22

Reporting Person: Solomon Jonathan Eitan (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-22	Common Stock Options - Right to Buy	$0.66	A	100000	Acquired	2032-08-22	Common Stock (100000)	Direct

Footnotes

F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on August 22, 2023, and the remainder vesting in 12 equal quarterly installments over three years.